SPC130

Lenvatíníb, að meðtöldu lenvatíníb mesýlati

  • Status:
    Veitt
  • Application date:
    17.11.2015
  • Application published:
    15.12.2015
  • Grant published:
    15.12.2017
  • Max expiry date:
    21.6.2030
  • Next due date:
    31.12.2025
  • Medicine name:
    Lenvima
  • Medicine for children:
    Yes

Timeline

Today
17.11.2015Application
15.12.2015Publication
15.12.2017Registration
21.12.2025Expires

Marketing license

  • IS authorization number:
    EU/1/15/1002/001; EU/1/15/1002/002
  • Date:
    15.6.2015
  • Foreign authorization number:
    EU/1/15/1002
  • Date:
    28.5.2015

Owner

  • Name:
    Eisai R&D Management Co., Ltd.
  • Address:
    6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 23.12.2024

Expires: 21.12.2025

Payer:

Number: 2

Paid: 19.11.2025

Expires: 21.12.2025

Payer: G.H. Sigurgeirsson ehf.

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 10.10.2025

Upload documents